US Grants Approval for GSK’s Breakthrough Antibiotic Targeting Urinary Tract Infections

In a significant advancement for the treatment of urinary tract infections (UTIs), the United States Food and Drug Administration (FDA) has officially approved a novel antibiotic developed by GlaxoSmithKline (GSK). This newly approved medication offers a promising alternative for patients suffering from the pervasive and often recurrent health issue of UTIs.

Continue reading

Superbugs: The Silent Threat to Global Meat Supply

In fact, the spread of AMR superbugs has reached a critical point and poses a critical challenge to the global meat industry. Resistance to most conventional treatments makes these pathogens one of the most significant threats to the stability of the global supply chain in meat. The many ramifications of this budding crisis are far-reaching from within the meat industry itself to raising an alarm among health professionals, economists, and policymakers alike.

Continue reading